Treatment Options From 5 Experts for Newly Diagnosed Follicular Lymphoma: An Online Tool
Article
Welcome to 2019
Watch for new videos, new articles, new discussions. Thank you for being a part of our story.
Benjamin Levy, MD, Faculty and Board Member
Dr. Benjamin Levy is a thoracic medical oncologist and the clinical director of medical oncology for the Johns Hopkins Sidney Kimmel Cancer Center at Sibley Memorial Hospital, as well as an assistant professor of oncology for Johns Hopkins University School of Medicine. Dr. Levy is board certified in medical oncology and hematology by the American Board of Internal Medicine. He practices out of the Johns Hopkins Sidney Kimmel Cancer Center at Sibley Memorial Hospital.
JOIN GRACE - Live in Seattle, November 10, 2018 ~Local Therapies for Metastatic Lung Cancer
Article
Happy 10 Year Birthday, GRACE!
Video
GRACE is celebrating our 10 year anniversary! Dr. H. Jack West and the GRACE community have been helping each other since before that time but in this 10th year as a non-profit, we are pleased and humbled by the feedback and graciousness of those we have the pleasure to work with, and those who have found help and support through our GRACE site.
Robert C. Doebele, M.D., Ph.D., GRACE Faculty
Dr. Doebele joined the faculty at University of Colorado Denver in July of 2008 as a member of the Thoracic Malignancies Program.
Gregory J. Riely, MD, PhD, GRACE Faculty
Dr. Riely is a board-certified medical oncologist who specializes in treating patients with lung cancer and thymic tumors (thymoma and thymic carcinoma). In addition to caring for men and women with these diseases, he works to develop new treatments by designing and conducting clinical trials. His clinical research focuses on the treatment of patients with thymic tumors as well as non-small cell lung cancer with specific mutations (EGFR, KRAS, BRAF, or EML4-ALK mutant non-small cell lung cancer).
David Ross Camidge, MD, PhD, GRACE Faculty
Dr. Camidge is the Director of Thoracic Oncology at the University of Colorado.
Case Based Panel Discussion - Advanced Non Squamous NSCLC, High PD-L1, No Driver Mutation - What is the Optimal 1st Line?
Video
Drs Zofia Piotrowska, H. Jack West, and Taofeek Owonikoko sit down to discuss a series of case-based scenarios. In this video, the doctors discuss the optimal 1st line treatment for a patient with advanced non squamous non small cell lung cancer, high PD-L1, and no driver mutation.
Case Based Panel Discussion - Advanced Non Squamous NSCLC, Low PD-L1 No Driver Mutation - Is There a Best Systemic Therapy Option?
Video
Drs Zofia Piotrowska, H. Jack West, and Taofeek Owonikoko sit down to discuss a series of case-based scenarios. In this video, the doctors discuss if there is a best systemic therapy option for a patient with advanced non-squamous NSCLC, low PD-L1 and no driver mutation.
Case Based Panel Discussion - What is the Optimal Approach for a Fit Patient with Advanced Squamous NSCLC and Low Tumor PD-L1 Expression
Video
Drs Zofia Piotrowska, H. Jack West, and Taofeek Owonikoko sit down to discuss a series of case-based scenarios. In this video, the doctors discuss the optimal approach for a fit patient with advanced squamous NSCLC and low tumor PD-L1 expression.
Pages
